|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biology, Saint Louis University, St. Louis, Missouri
Submitted 17 November 2004 ; accepted in final form 27 April 2005
Sensitivity of glucose transport to stimulation by insulin has been shown to occur concomitant with activation of the AMP-activated protein kinase (AMPK) in skeletal muscle, suggesting a role of AMPK in regulation of insulin action. The purpose of the present study was to evaluate a possible role of AMPK in potentiation of insulin action in muscle cells. The experimental model involved insulin-responsive C2C12 myotubes that exhibit a twofold increase in glucose transport in the presence of insulin. Treatment of myotubes with the AMPK activator 5-aminoimidazole-4-carboxamide-1-
-D-ribofuranoside (AICAR), followed by a 2-h recovery, augmented the ability of insulin to stimulate glucose transport. Similarly, incubation in hyperosmotic medium, another AMPK-activating treatment, acted synergistically with insulin to stimulate glucose transport. Furthermore, the increase in insulin action caused by hyperosmotic stress was prevented by inclusion of compound C, an AMPK inhibitor, in hyperosmotic medium. In addition, iodotubercidin, a general kinase inhibitor that is effective against AMPK, also prevented the combined effects of insulin and hyperosmotic stress on glucose transport. The new information provided by these data is that previously reported AICAR effects on insulin action are generalizable to myotubes, hyperosmotic stress and insulin synergistically increase glucose transport, and AMPK appears to mediate potentiation of insulin action.
indinavir; adenosine 5'-monophosphate-activated protein kinase; acetyl coenzyme A carboxylase; C2C12 myotubes; wortmannin
This article has been cited by other articles:
![]() |
S. Park, T. L. Scheffler, A. M. Gunawan, H. Shi, C. Zeng, K. M. Hannon, A. L. Grant, and D. E. Gerrard Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle Am J Physiol Cell Physiol, January 1, 2009; 296(1): C106 - C115. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujii, R. C. Ho, Y. Manabe, N. Jessen, T. Toyoda, W. L. Holland, S. A. Summers, M. F. Hirshman, and L. J. Goodyear Ablation of AMP-Activated Protein Kinase {alpha}2 Activity Exacerbates Insulin Resistance Induced by High-Fat Feeding of Mice Diabetes, November 1, 2008; 57(11): 2958 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P Turcotte and J. S Fisher Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise Physical Therapy, November 1, 2008; 88(11): 1279 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kim, G. Kewalramani, P. Puthanveetil, V. Lee, U. Kumar, D. An, A. Abrahani, and B. Rodrigues Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase Dependent Actin Cytoskeleton Organization Diabetes, January 1, 2008; 57(1): 64 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Brown, M. Elstner, S. J. Yeaman, D. M. Turnbull, and M. Walker Does impaired mitochondrial function affect insulin signaling and action in cultured human skeletal muscle cells? Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E97 - E102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Ju, M. A. Gitcho, C. A. Casmaer, P. B. Patil, D.-G. Han, S. A. Spencer, and J. S. Fisher Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase Am J Physiol Cell Physiol, January 1, 2007; 292(1): C564 - C572. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sriwijitkamol, J. L. Ivy, C. Christ-Roberts, R. A. DeFronzo, L. J. Mandarino, and N. Musi LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E925 - E932. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |